Phase 3 N=179 Effect of Preoperative Tamsulosin on Postoperative Urinary Retention
Postoperative Retention of Urine
Primary: Number of Participants With Postoperative Urinary Retention — 14; 16 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=151 Prevention of Post-operative Urinary Retention
Urinary Retention · Urinary Tract Infections
Primary: Need for Any Intermittent Catheterization Postoperatively as a Binary Outcome — 18; 22 Participants
N/A N=491 Urinary Retention After Laparoscopic Inguinal Hernia Repair: Comparing the Use of the Intraoperative Urinary Catheter
Inguinal Hernia
Primary: Number of Participants With Post Operative Urinary Retention — 23; 21 Participants
N/A N=84 Treatment for Acute Postoperative Voiding Dysfunction
Urinary Retention
Primary: Persistent Retention — 29; 21 participants
N/A N=84 Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial
Urinary Retention · Voiding Disorders
Primary: Number of Participants With Void Trial Failure Rate — 7; 11 Participants
Phase 3 N=20 Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension
Postoperative Urinary Retention · Sacrospinous Vaginal Vault Suspension · Reconstructive Pelvic Surgery
Primary: Number of Participants With Postoperative Urinary Retention — 11 Participants
Phase 3 N=132 Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery
Urinary Retention · Lower Urinary Tract Symptoms · Stress Urinary Incontinence
Primary: Postoperative Urinary Retention — 16; 5 Participants
Phase 4 N=50 Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block
Neuromuscular Blockade
Primary: Urine Residual in PACU — 219; 222 ml
Phase 3 N=171 The POUR (Postoperative Urinary Retention) Study
Postoperative Urinary Retention
Primary: Number of Participants With Urinary Retention — 0; 11; 74; 63 Participants
N/A N=158 Self-discontinuation of a Transurethral Catheter
Postoperative Urinary Retention
Primary: Number of Participants With Postoperative Urinary Retention — 11; 11 Participants — p=0.5
N/A N=142 Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery
Urinary Retention
Primary: Number of Participants With Acute Urinary Retention — 6; 7 Participants
Phase 3 N=152 Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
Urinary Retention Postoperative
Primary: Number of Participants With Postoperative Urinary Retention After Pelvic Organ Prolapse Surgery (INTENT-TO-TREAT) — 30; 25 Participants
Phase 4 N=150 The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling
Stress Urinary Incontinence
Primary: Number of Subjects With Urinary Retention — 15; 14 Participants
Phase 4 N=98 Assessing Pyridium for Post-Sling Urinary Retention
Urinary Retention
Primary: Number of Participants Considered to Have Passed Their Voiding Trial — 30; 30 Participants
N/A N=388 RCT Foley Catheter Study for Elective TJA
Postoperative Urinary Retention · Total Hip Arthroplasty · Total Knee Arthroplasty
Primary: Number of Patients Who Developed Postoperative Urinary Retention (POUR), Unable to Void a Volume Greater Than or Equal to 30ml/hr — 4; 5 Participants
N/A N=101 Prostatic Urethral Lift in Subject With Acute Urinary Retention
Acute Urinary Retention · Benign Prostatic Hyperplasia
Primary: Successful Trial Without Catheter Peri-procedurally — 29; 0 Participants
N/A N=64 Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery
Pelvic Organ Prolapse · Urinary Incontinence,Stress · Surgery
Primary: Failed Office Voiding Trials — 7; 1 Participants
N/A N=104 Spontaneous Void Requirements for Patients Undergoing Ambulatory Anorectal Surgery
Complications, Postoperative
Primary: PACU Time — 129.1; 210.0 Minutes
N/A N=49 Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter
Bladder Dysfunction · Urinary Retention
Primary: Total Catheter Related Pain — 1.25; 2.3 units on a scale
Phase 4 N=48 Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Pain, Postoperative · Urethral Stricture
Primary: Participant Pain Control: Numerical Rating Scale (NRS) — 1.2; .625 score on a scale
Phase 4 N=610 Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
Post-operative Urinary Retention
Primary: Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention — 23; 25 Participants — p=.96
Phase 4 N=235 Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
Urinary Retention Postoperative · Laparoscopic Cholecystectomy · Neuromuscular Blockade
Primary: Number of Participants With Postoperative Urinary Retention (POUR) of Sugammadex and Neostigmine Groups — 20; 6 Participants
Phase 4 N=154 Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery
Pelvic Organ Prolapse
Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97
N/A N=69 Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery
Urinary Incontinence
Primary: Number of Participants Who Passed Bladder Trial — 25; 39 participants
Phase 4 N=242 Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
Urinary Tract Infections
Primary: Urinary Tract Infection — 11; 12 UTI
Phase 4 N=94 Oral Nutrition After Regular Radical Cystectomy
Post Cystostomy
Primary: the Postoperative Length of Stay — 18; 14 day — p=<0.001
Phase 2 N=161 Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy
Urinary Retention Postoperative
Primary: Time to Spontaneous Void — 1.63; 1.42 hours
Phase 4 N=60 Comparison of Obturator Nerve Blockade and Neuromuscular Blockade
Cancer of Bladder
Primary: Number of Patients With Incidence of Intraoperative Adductor Spasm — 1; 5 Participants
Phase 2 N=337 Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Pelvic Organ Prolapse
Primary: Number of Participants With Treatment Failure Defined as Subsequent Treatment for Urinary Incontinence, Signs or Symptoms of Bothersome Urinary Incontinence — 39; 85…
N/A N=52 Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy
Prostate Cancer
Primary: Catheter Related Pain: Visual Analog Score Rating — 2.67; 2.67 score on a scale